CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.
Epistemonikos ID: c514b7932b81b49e40b699c27e35ae8b631cbdc5
First added on: May 14, 2024